INSIGHTS ON PHARMACEUTICAL INSPECTION
-
Determining The Limit Of Detection In CCIT
Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.
-
What Is The Biggest Problem With Inspector Training And Qualification?
Discover how a truly blind system eliminates bias from the human inspection process, improving data accuracy and validation of automated inspection systems.
-
Qualicaps Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging
Explore how a new capsule inspection system helps manufacturers overcome labor shortages, increase throughput, and maintain quality while meeting global compliance standards.
-
A Comprehensive Guide To Sampling Protocols And Robust CCI Testing
Effective CCI testing hinges on strategic sampling and statistical rigor. Learn why 30 samples matter, how positive controls validate defect detection, and why risk assessment ensures long-term reliability.
-
Ensuring Integrity: A Comprehensive Approach To CCI1/8/2026
Deterministic CCI testing ensures compliance in packaging. Learn how advanced methods like Vacuum Decay, HVLD, and Helium Leak Detection deliver results aligned with USP 1207 and global standards.
-
Increasing Quality And Reducing Costs With AI-Powered Inspection8/1/2024
AI-supported inspection processes offer a future-proof solution to the challenges of vision inspection. Learn how to get started with AI-supported inspection.
-
Are You Missing An Important Stage In Raw Material Product Inspection?4/23/2024
Learn why product inspection is crucial in ensuring safety and quality control for food manufacturers.
-
A Powerful Non-Destructive Tool For Tablet Characterization10/6/2025
Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.
-
Ensure Quality Control With Innovative Software7/1/2025
Ensure unmatched product quality with an X-ray system paired with an innovative software that detects contaminants and missing items in stacked packaged goods with precision.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
These unique materials are designed to address a wide range of application fields, delivering enhanced performance, reliability, and regulatory compliance for demanding end-use markets.
-
V31 Vision Inspection System
High speed, easy integration, and adaptable. Advanced package and label inspection of oriented products. The flexible system includes a rapid installation frame and product tracking for support of up to six cameras and customized lighting.
Increase Operational Efficiency
Automated visual inspection supports speeds up to 1,000 ppm, helping to save time and costs associated with manual quality control inspections.
Flexible Integration Options
The rapid installation frame, advanced camera, and lighting options fit various fields of view for a wide range of products.
Sophisticated Toolset
CIVCore software can perform multiple inter-dependent inspection criteria using powerful cameras for complex inspection applications.
-
Meet FDA guidelines for GMP in tablet and capsule production with a secure, failsafe system. Qualification reports are available.
-
Helium leak detection (HeLD) is routinely used and widely accepted for applications that require the utmost leak sensitivity. This brochure explains how Helium enables the discovery of extremely small microleaks that other leak testing methods cannot detect and what applications it can be used for.
-
As the governing regulatory document of the European Medicines Agency (EMA), EU GMP Annex 1 discusses a full host of concepts related to manufacture of sterile medicinal products. In contrast to guidance documents issued by the FDA, EU GMP Annex 1 is interpreted as law, requiring strict adherence to the regulatory expectations contained, numerous of which allude to container closure integrity testing. In fact, current proposed and ongoing revisions increase the expectations of scrutiny on package integrity.